PelleTune™ Caffeine SR-8 Pellets 65% w/w

Single-active release-modified functional pellet designed for reproducible eight-hour sustained release in a blend-compatible pellet format. 65% w/w caffeine; sustained release 8 h.

Caffeine SR-8 Pellets 65% w/w supplies Caffeine anhydrous in a multi-unit functional pellet with a product-specific food-grade coating system. It is intended as an independent formulation module for professional B2B use. Product-specific identity, assay, physical, microbiological, contaminant and stability controls are defined in the finished-product specification and verified by batch CoA.

What is Caffeine SR-8 Pellets 65% w/w?

Caffeine SR-8 Pellets 65% w/w supplies Caffeine anhydrous at 65% w/w caffeine in a multi-unit functional pellet with a product-specific food-grade coating system; its release behaviour is Sustained release 8 h.

What is the technical specification?

The key public specification is 65% w/w caffeine with Sustained release 8 h release behaviour; batch acceptance follows the approved product-specific specification and analytical method.

What is the public composition?

The public composition identifies Caffeine with a Food-grade pellet core, binder and product-specific functional coating; exact proprietary excipient ratios and supplier details remain controlled.

Country of origin is stated in the controlled Country of Origin Statement. Supplier and manufacturing-site information are not published.

Which formulation problem does this ingredient address?

A multi-unit pellet architecture separates the active from the formulation environment and delivers the defined sustained release 8 h behaviour.

• Defined sustained release 8 h performance
• multi-unit dosing
• coating-based protection
• blend-compatible target size.

Which applications are the best fit?

This ingredient is best suited to hard capsules and multi-unit sustained-release pellet systems.

How should formulators process and evaluate it?

• Blend with pellet populations of compatible particle size and bulk density. Avoid milling, crushing or compression conditions that damage the functional coating.
• Do not mill or open the coating system. Check segregation risk when blending with powders or pellets of materially different size or density.
• Confirm process compatibility, uniformity, stability and performance in the final matrix.

How is performance verified?

Performance is verified using approved product-specific methods and the controlled evidence listed below.

How should it be stored and handled?

Store tightly closed in original packaging in a cool, dry place, protected from heat, moisture and direct light. Free-flowing multi-unit pellets; colour and odour are product-specific. Avoid coating damage during handling.

Which technical and quality documents are available?

The following workbook-listed documents are available and customer-shareable. Controlled composition, characterisation or performance details may require an NDA where specified.

• Technical Data Sheet (TDS)
• Finished Product Specification
• Batch Certificate of Analysis (CoA)
• Safety Data Sheet (SDS)
• Allergen Statement
• GMO Statement
• Irradiation Statement
• BSE/TSE Statement
• Stability Documentation
• Composition / Ingredient Information
• Storage & Handling Information
• Microbiological Specification
• Heavy Metals Specification
• Country of Origin Statement
• Manufacturing / Quality Certificate
• Dissolution / Release Data

What must buyers confirm for regulatory and intended use?

Regulatory suitability depends on the intended use, dose and target market; the customer must confirm finished-product compliance.

How can B2B buyers evaluate and order it?

• Evaluation sample: 50 g — €35 ex VAT.
• Credited against first commercial order within 12 months
• Stocked MOQ: 1 kg.
• Standard formats: 1 kg; 5 kg; 25 kg.
• Standard lead time: 3–5 business days if in stock.
• Custom strength available: Yes, subject to feasibility.
• Custom release available: Yes, subject to development and validation.
• Private label / custom pack: Custom pack by quotation.
• Commercial terms confirmed by quotation.

What does NexaGens not claim?

No medicinal, disease-treatment or finished-product health claim is made. The stated release or protection function applies only when pellet integrity is maintained and the finished dosage form is validated. Finished-product classification, dose, permitted use, label declarations, nutrition or health claims and market compliance remain the customer’s responsibility.

Frequently asked questions

What documentation is available?

TDS, finished-product specification, batch CoA, SDS and the product-specific quality package are available. Dissolution/release data support the stated pellet function.

Can this product be combined with other ingredients?

Yes. This product may be combined with other independent NexaGens formulation modules after compatibility and finished-product validation.

What is the release format?

The release format is sustained release 8 h.

For professional B2B food, food-supplement and formulation use only. Not for direct consumer use.